The Food and Drug Administration gives approval for a new version of Wegovy, a popular diabetes medicine, to be sold as a weight-loss drug
Since its approval, tirzepatide has been praised for its ability to improve glycemic control and promote weight loss, two critical factors in managing type 2 diabetes
In breast cancer cells, a high level of miR-378* induces the metabolic shift from an oxidative to a glycolytic bioenergetics pathway by inhibiting the expression of two PGC-1 partners, ERR (estrogen-related receptor gamma) and GABPA (GA binding protein transcription factor, alpha subunit)
PlexusDx has no commercial relationship with Noom and runs its own protocol-based model in the GLP-1 space
But this isnt a unique mechanism of action for Semaglutide
Khan AA, Alsahli MA, Rahmani AH